|
🐜
|
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
8 auth.
C. Mihai,
R. Dobrota,
Maria Schröder,
A. Garaiman,
S. Jordan,
M. Becker,
...
B. Maurer,
O. Distler
|
6 |
2020 |
6
🐜
|
|
🦁
|
The Hospital Anxiety and Depression Scale in patients with systemic sclerosis: a psychometric and factor analysis in a monocentric cohort.
8 auth.
A. Garaiman,
C. Mihai,
R. Dobrota,
S. Jordan,
B. Maurer,
Jan Flemming,
...
O. Distler,
M. Becker
|
4 |
2021 |
4
🦁
|
|
🐜
|
Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
23 auth.
M. Becker,
R. Dobrota,
A. Garaiman,
Rudolf Debelak,
K. Fligelstone,
A. Tyrrell Kennedy,
A. Roennow,
Y. Allanore,
P. Carreira,
L. Czirják,
...
C. Denton,
R. Hesselstrand,
G. Sandqvist,
O. Kowal-Bielecka,
C. Bruni,
M. Matucci-Cerinic,
C. Mihai,
A. Gheorghiu,
U. Mueller-Ladner,
J. Sexton,
T. Kvien,
T. Heiberg,
O. Distler
|
4 |
2021 |
4
🐜
|
|
🦁
|
Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
9 auth.
A. Garaiman,
F. Nooralahzadeh,
C. Mihai,
Nicolas Andres Perez Gonzalez,
N. Gkikopoulos,
M. Becker,
...
O. Distler,
M. Krauthammer,
B. Maurer
|
3 |
2022 |
3
🦁
|
|
🐜
|
Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis
8 auth.
N. Zampatti,
A. Garaiman,
S. Jordan,
R. Dobrota,
M. Becker,
B. Maurer,
...
O. Distler,
C. Mihai
|
3 |
2021 |
3
🐜
|
|
🦁
|
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model.
22 auth.
A. Garaiman,
K. Steigmiller,
C. Gebhard,
C. Mihai,
R. Dobrota,
C. Bruni,
M. Matucci-Cerinic,
J. Henes,
J. D. de Vries-Bouwstra,
V. Smith,
...
A. Doria,
Y. Allanore,
L. Dagna,
B. Anić,
C. Montecucco,
O. Kowal-Bielecka,
Mickaël Martin,
Yoshiya Tanaka,
A. Hoffmann-Vold,
U. Held,
O. Distler,
M. Becker
|
3 |
2022 |
3
🦁
|
|
🐜
|
Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review.
25 auth.
A. Dima,
M. Vonk,
A. Garaiman,
BE Kersten,
R. Bečvář,
M. Tomčík,
A. Hoffmann-Vold,
I. Castellví,
Jl Tandaipan Jaime,
M. Brzosko,
M. Milchert,
D. Krasowska,
M. Michalska-Jakubus,
P. Airò,
M. Matucci-Cerinic,
...
C. Bruni,
M. Iudici,
J. Distler,
A. Gheorghiu,
H. Poormoghim,
F. Motta,
M. De Santis,
M. Pârvu,
O. Distler,
C. Mihai
|
2 |
2024 |
2
🐜
|
